medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 4

<< Back Next >>

Med Int Mex 2020; 36 (4)

Incidence of eclampsia in intensive care in Matamoros, Tamaulipas, Mexico

Maldonado-Mancillas JA, Tinoco-Álvarez MA, De la Garza-Longoria RS, González-Mendoz SZ

Language: Spanish
References: 15
Page: 485-491
PDF size: 189.02 Kb.


ABSTRACT

Background: According to the Health Ministry of Mexico, preeclampsia represents up to 34% of total maternal deaths. In addition, there are other entities associated with hypertension during pregnancy, such as eclampsia, and in much lower frequency, the HELLP syndrome (hemolysis elevated liver enzymes and low platelets). Together, the latter constitute the main cause of death associated with pregnancy complications.
Objective: To know the incidence of eclampsia cases entering an intensive care unit and the age group most susceptible to mortality.
Material and Method: An observational, retrospective and cross-sectional study was done using the journal of income and expenditures of the ICU, General Hospital of Matamoros, Tamaulipas, Mexico, from January 2012 to December 2018; each variable was statistically analyzed.
Results: Of the 2497 patients admitted to the intensive care unit, 227 cases were from Gynecology and Obstetrics. Of these, 206 were diagnosed with general pregnancy complications, in the age group of 13 to 46 years. Eclampsia was found in 48 patients (23.3%), predominating the age of 18 years.
Conclusions: In general, eclampsia represented up to 6.3% of the total number of patients admitted with a complicated pregnancy. In comparison to those reported by the Ministry of Health in 2007, the percentage in this hospital has been reduced up to 34%.


REFERENCES

  1. Sánchez-Rodríguez EN, Nava-Salazar S, Morán C, Romero- Arauz JF, Cerbón-Cervantes MA. Estado actual de la preeclampsia en México: de lo epidemiológico a sus mecanismos moleculares. Revista de Investigación Clínica 2010; 62: 252-260

  2. Miniño Arialdi M, Arias Elizabeth, Kochanek Kenneth D, Murphy Sherry L, Smith Betty L, Division of vital statistics. Volume 50, Number 15 http://ghdx.healthdata.org/series/ united-states-national-vital-statistics-system-nvss

  3. Barreto Rivero S. Preeclampsia severa, eclampsia y síndrome HELLP. Características maternas y resultado neonatal. Unidad de cuidados intensivos maternos. Instituto Materno Perinatal. Lima, Perú 1999-2000. Instituto Materno Perinatal. Lima, Perú. Red de revistas científicas de América Latina y el Caribe, España y Portugal. https://www.redalyc.org/html/912/91221104/

  4. Curiel-Balsera E, Prieto-Palomino MÁ, Muñoz-Bono J, Ruiz de Elvira MJ. Análisis de la morbimortalidad materna de las pacientes con preeclampsia grave, eclampsia y síndrome HELLP que ingresan en una Unidad de Cuidados Intensivos gineco-obstétrica. Med Intensiva 2011; 35(8): 478-483

  5. Hamilton BE, Martin JA, Ventura SJ, National Vital Statistics Reports 2000.

  6. Hellamn, Leveno, Pritchard JA. Ginecología Obstetricia Williams, 25ª ed, México, 2019.

  7. Lipstein H, Lee CC, Crupi RS. A current concept of eclampsia. Am J Emerg Med 2003; 21(3): 223-6. doi: 10.1016/s0735- 6757(02)42241-3

  8. Zetina F. La preeclampsia y la eclampsia. Ginecol Obstet Mex 2011;79(3):156-162.

  9. López-Llera M, Rubio Linares G, Hernández Horta JL. Maternal mortality rates in eclampsia. AJOG 1976; 124: 149-155. https://doi.org/10.1016/S0002-9378(16)33291-4

  10. Ramos de Amorim MM, Santos LC, Feitosa Porto AM, Dias Martins L. Risk factors for maternal death in patients with severe preeclampsia and eclampsia. Rev Bras Saude Mater 2001; 1. https://doi.org/10.1590/S1519- 38292001000300004

  11. Langer A, Villar J, Tell K, Kim T, Kennedy S. Reducing eclampsia-related deaths--a call to action. Lancet 2008. doi: 10.1016/S0140-6736(08)60321-9

  12. Lumbiganon P, Gülmezoglu M, Piaggio G, Langer A, Grimshaw J. Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be. Bull World Health Organ 2007. doi: 10.2471/ BLT.06.037911

  13. Raps EC, Galetta SL, Broderick M, Atlas SW. Delayed peripartum vasculopathy: Cerebral eclampsia revisited. Ann Neurol 1993; 33(2): 222-5. doi: 10.1002/ ana.410330215

  14. Briones Garduño JC, Díaz de León-Ponce M, González- Vargas Á, Briones-Vega CG. Resultado perinatal con tratamiento conservador en la preeclampsia eclampsia. Reporte preliminar. Cir Cir 2003; 71: 112-115.

  15. De la Garza-Longoria RS, Maldonado Mancillas JA, Mendoza- Múzquiz PL, Sánchez L. Incidencia de enfermedad cerebrovascular en un servicio de Medicina Interna. Med Int Méx 2018; 34(6): 874-880. DOI: https://doi.org/10.24245/ mim.v34i6.2062




2020     |     www.medigraphic.com